PRO051: Clinical Trials

1 trial of PRO051, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow PRO051: new trials by email Literature Review of PRO051 trials Research Report on PRO051

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects
Drisapersen - Muscular Dystrophies
Phase 3TerminatedBioMarin Pharmaceutical532013-05-012018-06-14

Conditions studied

Muscular Dystrophies (1)  ·  Muscular Dystrophy, Duchenne (1)

Sponsors

BioMarin Pharmaceutical (1)

Countries

Canada (1)  ·  United States (1)